{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:22:50Z","timestamp":1765758170934},"reference-count":14,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3714,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidem. Drug Safe."],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1002\/pds.1099","type":"journal-article","created":{"date-parts":[[2005,4,20]],"date-time":"2005-04-20T16:48:35Z","timestamp":1114015715000},"page":"501-506","source":"Crossref","is-referenced-by-count":16,"title":["Anti-infectives-induced adverse drug reactions in hospitalized patients"],"prefix":"10.1002","volume":"14","author":[{"given":"K.","family":"Gholami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Shalviri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Assasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1002\/pds.1099-BIB1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"Lazarou","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1002\/pds.1099-BIB2","first-page":"28","volume":"9","author":"Goldwater","year":"1997","journal-title":"Drug Benefit Trends"},{"key":"10.1002\/pds.1099-BIB3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ajhp\/52.3.297","volume":"52","author":"Johnston","year":"1995","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1002\/pds.1099-BIB4","first-page":"46","volume":"24","author":"Smith","year":"1999","journal-title":"US Pharmacist"},{"key":"10.1002\/pds.1099-BIB5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1345\/aph.17440","volume":"33","author":"Gholami","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1002\/pds.1099-BIB6","first-page":"209","volume-title":"Principles and Practice of Infectious Diseases","author":"Moellering","year":"1995","unstructured":". Principles of anti-infective therapy. In Principles and Practice of Infectious Diseases (4th edn). Churchil Livingstone, Inc.: New York, 1995; 209."},{"key":"10.1002\/pds.1099-BIB7","first-page":"261","volume-title":"Averys Drug Treatment","author":"Edwards","year":"1997","unstructured":". Pharmacological basic of adverse drug reaction. In Averys Drug Treatment (4th edn). Adis International limited: New Zealand, 1997: 261-299."},{"key":"10.1002\/pds.1099-BIB8","year":"1996","unstructured":"WHO collaborating center for international drug monitoring, the Uppsala Monitoring Centre. Adverse reaction Terminology, 1996."},{"key":"10.1002\/pds.1099-BIB9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00002018-199716060-00002","volume":"16","author":"Meyboom","year":"1997","journal-title":"Drug saf"},{"key":"10.1002\/pds.1099-BIB10","author":"World Health Organization","year":"1996","unstructured":"World Health Organization. Safety monitoring of medical product. Guidelines for setting up and running a pharmacovigilance centre. Geneva, 1996, 19."},{"key":"10.1002\/pds.1099-BIB11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00002018-199717060-00004","volume":"16","author":"Meyboom","year":"1997","journal-title":"Drug saf"},{"key":"10.1002\/pds.1099-BIB12","first-page":"101","volume-title":"Pharmacotherapy, A Pathophysiologic Approach","author":"May","year":"1997","unstructured":". Adverse drug reactions and interactions. In Pharmacotherapy, A Pathophysiologic Approach. Appleton and Lange A Simon and Schuster Company: Stamford, CT, 1997; 101-116."},{"key":"10.1002\/pds.1099-BIB13","first-page":"141","volume":"43","author":"Hallas","year":"1996","journal-title":"Dan Med Bull"},{"key":"10.1002\/pds.1099-BIB14","author":"American Hospital Formulary Service","year":"1999","unstructured":"American Hospital Formulary Service. American society of Health-system pharmacists, Inc., 1999."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1099","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.1099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:17:17Z","timestamp":1625354237000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.1099","relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}